Medsender
PrivateLast Round
Series A
Jan 30, 2025
Total Funding Raised
$7.49M
Company Overview
Medsender operates in Enterprise Software and is based in New York City, New York. Its latest recorded funding round was a Series A round in January 2025.
Medsender is a healthcare technology company that provides an AI-powered administrative workflow and communication platform designed to automate tasks for medical practices.
Sector
Enterprise Software
Verticals
Vertical SaaS, EHR & EMR, NLP & Conversational AI, Workflow Automation, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medsender Comparables
Compare Medsender with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spruce Health | 83% | |
| Titan Intake | 81% | |
| Tennr | 80% |
For institutional investors. Book with your work email.
Medsender Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2025 | ||||
| Seed | Dec 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medsender Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ballast Point Ventures | Series A |
| 450 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2025
Named to the 2025 list of America's fastest-growing private companies.
- Jul 23, 2025
Added Frontier Dermatology, a small healthcare provider, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withOct 14, 2026
On Oct 14th '26 in New York, Medsender, Inc. integrates directly with ModMed's ModMed EMA to automate the complete referral workflow, including AI-powered fax processing, referral routing, and tracking through scheduled appointments.
- launchesOct 13, 2026
Medsender launches Agentic Referral Management in New York on Oct 13th '26; the software processes referrals in under 30 seconds and contacts referred patients by text, email, and phone to help turn more referrals into booked appointments.
- recognized_asAug 19, 2026
Inc. names New York-based Medsender, Inc. to the 2026 Inc. 5000, where it ranks No. 621 among America’s fastest-growing private companies and earns its second consecutive appearance on Aug 19th '26.
- recognized_asAug 19, 2026
The 2026 Inc. 5000 names Medsender, Inc. No. 621 among America's fastest-growing private companies in New York on Aug 19th '26, marking its second consecutive appearance.
- recognized_asAug 19, 2026
Inc. names Medsender, Inc. to its 2026 Inc. 5000 of America’s fastest-growing private companies, where it ranks No. 621 for its second consecutive year, in New York on Aug 19th '26.
For institutional investors. Book with your work email.
Medsender Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medsender's valuation, stock price, and market status.
Is Medsender a public or private company?
Medsender is a private company.
What is the current stock price of Medsender?
Medsender is a private company, so its shares have no public market price. Caplight tracks Medsender's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medsender worth (valuation)?
Valuation information for Medsender is not publicly available.
Can I buy Medsender stock?
Medsender shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medsender's last funding round?
Medsender's most recent funding round was Series A on January 30, 2025.
Who are the main investors in Medsender?
Key investors in Medsender include Ballast Point Ventures.
Will Medsender IPO soon?
No public IPO plans have been announced for Medsender.
How can I track Medsender secondary market activity?
Caplight tracks bids, offers, and trades in Medsender's shares on secondary markets.